إعلان
إعلان
BOLT
Bolt Biotherapeutics, Inc. Common Stock
5.83
USDبرعاية
+0.02
+0.34%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
5.64
-0.19
-3.26%
تقارير أرباح BOLT
النسبة الإيجابية المفاجئة
BOLT تفوق 15 من 20 آخر التقديرات.
75%
التقرير التالي
بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$680.00K
/-$6.22
التغير الضمني من Q3 25 (Revenue/ EPS)
-68.65%
/+67.20%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-18.16%
Bolt Biotherapeutics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, BOLT reported earnings of -3.72 USD per share (EPS) for Q3 25, beating the estimate of -5.90 USD, resulting in a 36.99% surprise. Revenue reached 2.17 مليون, compared to an expected 739.50 ألف, with a 193.31% difference. The market reacted with a +0.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -6.22 USD, with revenue projected to reach 680.00 ألف USD, implying an زيادة of 67.20% EPS, and نقصان of -68.65% in Revenue from the last quarter.
الأسئلة الشائعة
What were Bolt Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bolt Biotherapeutics, Inc. Common Stock reported EPS of -$3.72, beating estimates by 36.99%, and revenue of $2.17M, 193.31% above expectations.
How did the market react to Bolt Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.21%, changed from $4.69 before the earnings release to $4.70 the day after.
When is Bolt Biotherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
What are the forecasts for Bolt Biotherapeutics, Inc. Common Stock's next earnings report?
Based on 7
المحللين, Bolt Biotherapeutics, Inc. Common Stock is expected to report EPS of -$6.22 and revenue of $680.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان